Intrinsic Value of S&P & Nasdaq Contact Us

Talkspace, Inc. TALK NASDAQ

NASDAQ Global Select • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
54/100
2/7 Pass
SharesGrow Intrinsic Value
$11.95
+131.1%
Analyst Price Target
$5.42
+4.8%

Talkspace, Inc. (TALK) is a Medical - Care Facilities company in the Healthcare sector, currently trading at $5.17. It has a SharesGrow Score of 54/100, indicating a mixed investment profile with 2 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of TALK = $11.95 (+131.1% from the current price, the stock appears undervalued). Analyst consensus target is TALK = $5 (+4.8% upside).

Valuation: TALK trades at a trailing Price-to-Earnings (P/E) of 111.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 1.96.

Financials: revenue is $229M, +24.2%/yr average growth. Net income is $8M, growing at +127.3%/yr. Net profit margin is 3.4% (thin). Gross margin is 43% (-7.5 pp trend).

Balance sheet: total debt is $0 against $117M equity (Debt-to-Equity (D/E) ratio 0, conservative). Current ratio is 6.38 (strong liquidity). Debt-to-assets is 0%. Total assets: $135M.

Analyst outlook: 2 / 10 analysts rate TALK as buy (20%) — mixed sentiment.

SharesGrow 7-Criteria breakdown: Value 48/100 (Partial), Growth 100/100 (Pass), Past 25/100 (Fail), Health 100/100 (Pass), Moat 42/100 (Fail), Future 34/100 (Fail), Income 30/100 (Fail).

$5.42
▲ 4.84% Upside
Average Price Target
Based on 10 Wall Street analysts offering 12-month price targets for Talkspace, Inc., the average price target is $5.42, with a high forecast of $6.00, and a low forecast of $5.00.
Highest Price Target
$6.00
Average Price Target
$5.42
Lowest Price Target
$5.00

TALK SharesGrow Score Overview

54/100
SharesGrow Score
Mixed signals — some strengths
View full scorecard →
VALUE 48/100
Valuation — P/E, PEG, Forward PEG
GROWTH 100/100
Financials — average growth
PAST 25/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 42/100
Gross margin is + market cap
FUTURE 34/100
Analyst outlook — as buy
INCOME 30/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — TALK

~
VALUE Partial
48/100
TALK trades at a trailing Price-to-Earnings (P/E) of 111.6 (S&P 500 average ~25). Forward PEG 1.96 — overvalued. Trailing PEG 1.35. Analyst consensus target is $5, implying -3.3% from the current price $5. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
100/100
TALK: +24.2%/yr revenue is, +127.3%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Fail
25/100
TALK: 1 / 4 years profitable. weak. Score = 1 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Pass
100/100
Balance sheet TALK: Debt-to-Equity (D/E) ratio 0 (conservative), Current ratio is 6.38 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
MOAT Fail
42/100
TALK: Gross margin is 43% (-7.5 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 42/100. ≥ 70 = Pass.
View details →
FUTURE Fail
34/100
Analyst outlook: 2 / 10 analysts rate TALK as buy (20%). Analyst consensus target is $5 (-3.3% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
INCOME Fail
30/100
TALK: Net profit margin is 3.4%. thin (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range2.22-5.19
Volume2.16M
Avg Volume (30D)4.18M
Market Cap$863.78M
Beta (1Y)1.14
Share Statistics
EPS (TTM)0.05
Shares Outstanding$168.43M
IPO Date2020-07-30
Employees521
CEOJon R. Cohen
Financial Highlights & Ratios
Revenue (TTM)$228.87M
Gross Profit$98.35M
EBITDA$11.24M
Net Income$7.79M
Operating Income$3.15M
Total Cash$92.59M
Net Debt$-37.35M
Total Assets$134.86M
Price / Earnings (P/E)110.9
Price / Sales (P/S)3.77
Analyst Forecast
1Y Price Target$5.25
Target High$6.00
Target Low$5.00
Upside+1.5%
Rating ConsensusHold
Analysts Covering10
Buy 20% Hold 80% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS87427V1035

Price Chart

TALK
Talkspace, Inc.  ·  NASDAQ Global Select
Healthcare • Medical - Care Facilities
2.22 52WK RANGE 5.19
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message